Bacterial 70S ribosome aminoacyl-tRNA binding site (A-site) (70S ribosome A-site)

The bacterial 70S ribosome aminoacyl-tRNA binding site (A-site) is a fundamental functional region within the bacterial translation machinery where the decoding of genetic information occurs. It is a complex site spanning both the 30S and 50S subunits, with its most critical component being the decoding center of the 16S ribosomal RNA (rRNA) in the 30S subunit [2, 6]. During the elongation phase of protein synthesis, the A-site facilitates the selection and binding of aminoacyl-tRNA molecules that match the mRNA codon currently being translated [6, 14]. This site is the primary target for several major classes of antibiotics, most notably aminoglycosides and tetracyclines, which are essential for treating a wide range of bacterial infections [1, 13]. Aminoglycosides bind to the A-site to decrease the fidelity of decoding, leading to lethal mistranslation, whereas tetracyclines physically block the A-site to prevent tRNA attachment and halt protein production [8, 13]. While the A-site is highly conserved among bacteria, its structural differences from the eukaryotic 80S ribosome allow for selective toxicity, though similarities with human mitochondrial ribosomes can lead to clinical side effects like ototoxicity and nephrotoxicity [9, 15]. The emergence of resistance, often through ribosomal mutations or enzymatic modifications of the drugs, remains a significant challenge in targeting this site [11, 13].

Other names

Ribosomal A-siteAminoacyl site16S rRNA decoding center30S A-site50S A-site

Antibiotics targeting the A-site primarily inhibit protein synthesis through two distinct mechanisms: aminoglycosides bind to the 16S rRNA decoding center to induce conformational changes that cause mRNA misreading and the production of aberrant proteins [2, 13], while tetracyclines and other classes sterically block the entry and positioning of aminoacyl-tRNA, thereby halting translation elongation [1, 8].